TASCOM Co., Ltd. engages in the research and development of cell therapy treatment for diabetes and in the supply and distribution of diabetic medical devices. Its products include blood sugar measurement system, pen needles, insulin syringe, sharps containers, safety lancets and others. The company was founded on March 11, 2014 and is headquartered in Anyang-si, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company